B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 8, 2008, Pages 2109-2116

  Xu, Xinran ^a   Gammon, Marilie D ^c   Wetmur, James G ^a   Bradshaw, Patrick T ^c   Teitelbaum, Susan L ^a   Neugut, Alfred I ^b   Santella, Regina M ^b   Chen, Jia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; NICOTINAMIDE; PROGESTERONE RECEPTOR; THIAMINE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARBON METABOLISM; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIETARY INTAKE; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TIME SERIES ANALYSIS; VITAMIN INTAKE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; VITAMIN B COMPLEX;

EID: 54049141769     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2900     Document Type: Article

References (49)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8,31, 1.
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
3. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
4. Page DL, Jensen RA, Simpson JF. Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 1998;51:195-208.
5. Osborne CK. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 1998;51:227-38.
6. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
7. Frei E. Section 31: The breast. In: Holland JF, Kufe DW, editors. Cancer medicine 6. Hamilton (Ontario): BC Decker, Inc; 2003. p. 1425.
8. Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast 2004;13:85-92.
9. Barnett JB. The relationship between obesity and breast cancer risk and mortality. Nutr Rev 2003;61:73-6.
10. Weitzen R, Tichler T, Kaufman B, Catane R, Shpatz Y. Body weight, nutritional factors and physical activity-their influence on prognosis after breast cancer diagnosis. Harefuah 2006;145:820,5, 861.
11. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-96.
12. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002;21:5462-82.
13. Tamoxifen for early breast cancer: An overview of the randomised trials. early breast cancer trialists' collaborative group. Lancet 1998;351:1451-67.
14. James CR, Quinn JE, Mullan PB, Johnston PG, Harkin DP. BRCA1, a potential predictive biomarker in the treatment of breast cancer. Oncologist 2007;12:142-50.
15. Yan PS, Chen CM, Shi H, et al. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 2001;61:8375-80.
16. Yang X, Yan L, Davidson NE. DNA methylation in breast cancer. Endocr Relat Cancer 2001;8:115-27.
17. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
18. Goldhirsch A, Colleoni M, Coates AS, Castiglione-Gertsch M, Gelber RD. Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: Are all CMFs alike? The international breast cancer study group (IBCSG). Ann Oncol 1998;9:489-93.
19. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511-9.
20. Cole BF. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9.
21. Ulrich CM, Potter JD. Folate and cancer - timing is everything. JAMA 2007;297:2408-9.
22. Gammon MD, Neugut AI, Santella RM, et al. The long island breast cancer study project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 2002;74:235-54.
23. Cleveland RJ, Eng SM, Abrahamson PE, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1803-11.
24. Gaudet MM, Britton JA, Kabat GC, et al. Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:1485-94.
25. Gammon MD, Santella RM, Neugut AI, et al. Environmental toxins and breast cancer on long island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 2002;11:677-85.
26. Xu X, Gammon MD, Wetmur JG, et al. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr 2007;85:1098-102.
27. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 1987;46:1016-28.
28. Hannon-Fletcher MP, Armstrong NC, Scott JM, et al. Determining bioavailability of food folates in a controlled intervention study. Am J Clin Nutr 2004;80:911-8.
29. Chen J, Gammon MD, Chan W, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005;65:1606-14.
30. Fink BN, Gaudet MM, Britton JA, et al. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat 2006;98:199-208.
31. Xu X, Gammon MD, Zhang H, et al. Polymorphisms of one-carbon metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007;28:1504-9.
32. Hosmer DW. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999.
33. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia (PA): Lippincott-Raven Publishers; 1998.
34. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
35. Chen Z, Karaplis AC, Ackerman SL, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001;10:433-43.
36. Schwahn BC, Chen Z, Laryea MD, et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J 2003;17:512-4.
37. Shrubsole MJ, Shu XO, Ruan ZX, et al. MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai breast cancer study. Breast Cancer Res Treat 2005;91:73-9.
38. Martin DN, Boersma BJ, Howe TM, et al. Association of MTHFR gene polymorphisms with breast cancer survival. BMC Cancer 2006;6:257.
39. Kesteloot HE, Verbeke G. On the relationship between all-cause, cardiovascular, cancer and residual mortality rates with age. Eur J Cardiovasc Prev Rehabil 2005;12:175-81.
40. D'Amico M, Agozzino E, Biagino A, Simonetti A, Marinelli P. Ill-defined and multiple causes on death certificates-a study of misclassification in mortality statistics. Eur J Epidemiol 1999;15:141-8.
41. Goldacre MJ. Cause-specific mortality: Understanding uncertain tips of the disease iceberg. J Epidemiol Community Health 1993;47:491-6.
42. Percy C, Dolman A. Comparison of the coding of death certificates related to cancer in seven countries. Public Health Rep 1978;93:335-50.
43. Percy C, Stanek E III, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71:242-50.
44. Jaffar S, Leach A, Smith PG, Cutts F, Greenwood B. Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia. Int J Epidemiol 2003;32:430-6.
45. Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 2000;88:674-84.
46. McBride CM, Clipp E, Peterson BL, Lipkus IM, Demark-Wahnefried W. Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology 2000;9:418-27.
47. Maunsell E, Drolet M, Brisson J, Robert J, Deschenes L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol 2002;20:1017-25.
48. Salminen EK. Does breast cancer change patients' dietary habits? Eur J Clin Nutr 2000;54:844-8.
49. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665-73.